Table 1.
Cancer | miR-200a expression | miR-200b expression | miR-200c expression | miR-141 expression | miR-429 expression | Ref. |
---|---|---|---|---|---|---|
Acute myeloid leukemia | ↓ | ↓ | n/d | n/d | ↓ | (31) |
Acute lymphoblastic leukemia | n/d | n/d | n/d | ↓ | ↑ | (32, 33) |
Bladder cancer | ↓/↑ | ↑ | ↓/↑ | ↑ | ↑ | (34–41) |
Breast cancer | ↓/↑ | ↓/↑ | ↓/↑ | ↓/↑ | n/d | (42, 43) |
Cervical carcinoma | ↓ | ↓ | ↓/↑ | ↑ | ↓ | (44–50) |
Cholangiocarcinoma | ↓ | ↓ | ↓ | n/d | n/d | (51, 52) |
Colorectal cancer | ↑ | ↑ | ↑ | ↑ | ↑/↓ | (53–59) |
Endometrial cancer | ↑ | ↑ | ↑ | ↑ | ↑ | (60, 61) |
Esophageal carcinoma | ↓/↑ | ↓ | ↓ | ↓ | ↓ | (62–70) |
Gastric cancer | ↓/↑ | ↓/↑ | ↓/↑ | ↓ | ↓/↑ | (71–76) |
Glioma | ↓ | ↓ | ↓ | ↓ | ↑/↓ | (77–83) |
Head and neck carcinoma | ↓ | n/d | n/d | ↓ | n/d | (84–86) |
Liver cancer | ↓ | ↓ | ↓ | ↓ | ↓ | (87–91) |
Melanoma | ↓ | ↓ | ↓ | ↓ | ↓ | (92–94) |
Nephroblastoma | ↓ | ↓ | ↓ | ↓ | ↓ | (95–98) |
Neuroblastoma | ↓ | n/d | n/d | n/d | n/d | (99) |
Non-small cell lung cancer | ↓ | ↓ | ↓ | ↑/↓ | ↑ | (100) |
Oral squamous cell carcinoma | ↓ | ↓ | ↓ | ↓ | ↓ | (101, 102) |
Osteosarcoma | ↓ | ↓ | ↓ | ↓ | ↓ | (103–107) |
Ovarian cancer | ↑ | ↑ | ↑ | ↑ | n/d | (108–113) |
Pancreatic cancer | ↑ | ↑ | ↓ | ↑/↓ | ↓ | (114–118) |
Prostate cancer | ↓/↑ | ↑ | ↓ | ↑ | n/d | (119–122) |
Renal cell carcinoma | ↓ | ↓ | ↓ | ↓ | ↓ | (123–128) |
Small cell lung carcinoma | n/d | n/d | n/d | n/d | n/d | n/d |
Thyroid cancer | ↓/↑ | ↓/↑ | ↓/↑ | ↓/↑ | ↓/↑ | (129–132) |
↓ - downregulated expression; ↑ - upregulated expression; n/d – no data.